Assignee
SPROUT PHARMACEUTICALS INC
US·15 granted patents·31 pending applications·9 citations·filing 2012–2021
Top patents by PatentIndex Score
46 records- 0183US9949969B2Treatment of vasomotor symptomsSPROUT PHARMACEUTICALS INC·Filed 2017·Granted Apr 24, 2018·3 cites·18 claims
- 0282US9730927B2Use of flibanserin in the treatment of obesitySPROUT PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·2 cites·20 claims
- 0378US9782403B2Treating sexual desire disorders with flibanserinSPROUT PHARMACEUTICALS INC·Filed 2016·Granted Oct 10, 2017·1 cites·20 claims
- 0477US10874668B2Use of Flibanserin in the treatment of obesitySPROUT PHARMACEUTICALS INC·Filed 2019·Granted Dec 29, 2020·0 cites·20 claims
- 0575US10166230B2Treatment of vasomotor symptomsSPROUT PHARMACEUTICALS INC·Filed 2014·Granted Jan 1, 2019·2 cites·17 claims
- 0675US9468639B2Treating sexual desire disorders with flibanserinSPROUT PHARMACEUTICALS INC·Filed 2015·Granted Oct 18, 2016·1 cites·20 claims
- 0774US10675280B2Treating sexual desire disorders with flibanserinSPROUT PHARMACEUTICALS INC·Filed 2019·Granted Jun 9, 2020·0 cites·25 claims
- 0873US2021069185A1Use of flibanserin in the treatment of obesitySPROUT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0971US2015057290A1Method of using flibanserin for neuroprotectionSPROUT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1070US11058683B2Treating sexual desire disorders with flibanserinSPROUT PHARMACEUTICALS INC·Filed 2020·Granted Jul 13, 2021·0 cites·22 claims
- 1170US10307420B2Treating sexual desire disorders with flibanserinSPROUT PHARMACEUTICALS INC·Filed 2018·Granted Jun 4, 2019·0 cites·20 claims
- 1269US2021308129A1Treating sexual desire disorders with flibanserinSPROUT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1367US10098876B2Treating sexual desire disorders with flibanserinSPROUT PHARMACEUTICALS INC·Filed 2017·Granted Oct 16, 2018·0 cites·20 claims
- 1467US2014044803A1Method of using flibanserin for neuroprotectionSPROUT PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1566US2015011563A1Treating Sexual Desire Disorders with FlibanserinSPROUT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1664US10335407B2Use of flibanserin in the treatment of obesitySPROUT PHARMACEUTICALS INC·Filed 2017·Granted Jul 2, 2019·0 cites·17 claims
- 1764US2014057923A1Treating Sexual Desire Disorders with FlibanserinSPROUT PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1863US2015004228A1Pharmaceutical compositions containing flibanserinSPROUT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1963US2013172304A1Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual DisordersSPROUT PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2061US2020253962A1Treatment of vasomotor symptomsSPROUT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2161US2014005203A1Treatment of Vasomotor SymptomsSPROUT PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2260US10596170B2Treatment of vasomotor symptomsSPROUT PHARMACEUTICALS INC·Filed 2018·Granted Mar 24, 2020·0 cites·18 claims
- 2360US2015005316A1Use of a polymorph of flibanserin for treating diseaseSPROUT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2459US2015157627A1Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual DisordersSPROUT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2559US2015238484A1Use of Flibanserin for the Treatment of Sexual Disorders in FemalesSPROUT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2659US2014010878A1Pharmaceutical compositions containing flibanserinSPROUT PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2758US2014031365A1Use of a polymorph of flibanserin for treating diseaseSPROUT PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2857US10004731B2Flibanserin for the treatment of urinary incontinence and related diseasesSPROUT PHARMACEUTICALS INC·Filed 2017·Granted Jun 26, 2018·0 cites·17 claims
- 2954US2016095855A1Use of a polymorph of flibanserin for treating diseaseSPROUT PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3054US2013203766A1Pharmaceutical Compositions for the Treatment of Sexual Disorders IISPROUT PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 3154US2016095819A1Pharmaceutical compositions containing flibanserinSPROUT PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3252US2015011564A1Sulfated Benzimidazolone Derivatives Having Mixed Serotonine Receptor AffinitySPROUT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3351US9763936B2Flibanserin for the treatment of urinary incontinence and related diseasesSPROUT PHARMACEUTICALS INC·Filed 2015·Granted Sep 19, 2017·0 cites·17 claims
- 3451US2015224058A1Formulations of flibanserinSPROUT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3551US2015051221A1Use of Flibanserin for the Treatment of Post-Menopausal Sexual Desire DisordersSPROUT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3651US2013203671A1Flibanserin for the Treatment of Urinary Incontinence and Related DiseasesSPROUT PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 3750US2014329827A1Use of flibanserin for the treatment of pre-menopausal sexual desire disordersSPROUT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3848US2015320739A1Pharmaceutical Compositions for the Treatment of Sexual Disorders IISPROUT PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3947US2013190326A1Use of flibanserin for the treatment of post-menopausal sexual desire disordersSPROUT PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 4047US2013225604A1Use of flibanserin for the treatment of pre-menopausal sexual desire disordersSPROUT PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 4146US9546141B2SaltsSPROUT PHARMACEUTICALS INC·Filed 2014·Granted Jan 17, 2017·0 cites·8 claims
- 4246US2013209519A1Formulations of flibanserinSPROUT PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 4344US2013197010A1Use of Flibanserin for the Treatment of Sexual Disorders in FemalesSPROUT PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 4442US2015368204A1Sulfated Benzimidazolone Derivatives Having Mixed Serotonine Receptor AffinitySPROUT PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4541US2015374683A1Use of Flibanserin for the Treatment of Post-Menopausal Sexual Desire DisordersSPROUT PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4640US2015366862A1Use of flibanserin for the treatment of pre-menopausal sexual desire disordersSPROUT PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SPROUT PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →